SJR90 Summary

• Expresses legislative support for Alabama's biotechnology industry, BioAlabama (the state affiliate of the Biotechnology Industry Organization), and the Alabama Biotechnology Legislative Caucus.

• Highlights Alabama's biotechnology sector comprising more than 550 bioscience establishments across agriculture, pharmaceuticals, medical devices, hospitals, and research laboratories.

• Recognizes Alabama's leadership in bioscience patents and clinical trials, and notes that a five-year delay in Alzheimer's disease onset could reduce cases by 1.6 million Americans with $50 billion in annual medical cost savings.

• Applauds dedicated biotechnology professionals and encourages development of public policies that support commercialization of innovative science, retain existing companies, and attract new bioscience organizations to Alabama.

• Encourages public awareness of Alabama's biotechnology industry and its economic and quality-of-life impacts on the state.